Toxic drug supply causing complex overdoses in Sudbury
Officials are warning that street drugs are being mixed with other substances, making Naxalone ineffective to combat overdoses.
Officials are warning that street drugs are being mixed with other substances, making Naxalone ineffective to combat overdoses.
Outreach workers and Public Health Sudbury and Districts say toxic overdoses have been increasing in the area lately.
Officials said illegal drugs are being cut with substances that Naloxone -- a medication for opioid overdoses – can't reverse.
Naxalone
Officials said illegal drugs are being cut with substances that Naloxone -- a medication for opioid overdoses – can't reverse.
(Alana Everson/CTV News)
In May, the Go Give Project said it handed out about 220 Naloxone kits, a fast-acting medication that reverses the effects of an opioid overdose.
But Ali Farooq, The Go Give Project co-founder, said it only works on opioid overdoses.
Increase in toxic overdoses
'While it will reverse the effects of the opioid that the individual is suffering, it will not have any other effect on any other contaminants or additives to the supply,' Farooq said.
He said outreach workers are seeing an increase in toxic overdoses, which he attributed to a more toxic drug supply.
'This usually ties in when we have big drug busts in the province and around the country,' Farooq said.
'It limits the supply coming in and therefore we find more and more contaminants mixed in with the drugs going out onto the streets.'
Sam Mortimer
Public Health nurse Sam Mortimer said it's a reminder of just how toxic the unregulated drug supply is and making overdoses more complex.
(Alana Everson/CTV News)
Public Health said it's a reminder of just how toxic the unregulated drug supply is and making overdoses more complex.
'Those sedatives and tranquilizers that have been added into the supply in recent years increase those effects,' said public health nurse Sam Mortimer.
'We are seeing people who are staying asleep or sedated for a lot longer, which puts them at a greater risk. And it also decreases their ability to breathe, which, again, puts them at risk for respiratory distress or arrest.'
Health unit officials said it's still vitally important to administer Naloxone in an overdose, call 911 and give rescue breaths while waiting for help.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
3 hours ago
- CBC
Federal court rules Health Canada decision to block experiential psilocybin training was unreasonable
Social Sharing The Federal Court of Appeal has ruled that Health Canada's refusal to allow exemptions for health-care workers to use psilocybin as part of their experiential training was unreasonable. Wednesday's decision was the result of an appeal of a 2022 judicial review application in a case involving 96 health-care practitioners who sought an exemption to legally use dried hallucinogenic mushrooms as part of what is known as experiential training. The initial application for exemption was filed under the name of Jeff Toth, a Nova Scotia nurse practitioner. Health Canada's refusal of the health-care workers' requests for exemptions has been sent back to Health Minister Marjorie Michel for redetermination. The mushrooms, commonly called magic mushrooms, contain psychoactive substances that are only legal for use in Canada if an exemption is granted under the Controlled Drugs and Substances Act (CDSA). Such exemptions are reserved for psilocybin-assisted psychotherapy, which involves medically supervised consumption of the substance for the treatment of serious medical conditions including end-of-life distress or treatment-resistant depression. Late Wednesday, the federal court ruled that Health Canada's reasons for refusing to grant exemptions to the 96 health workers training to administer psilocybin were too arbitrary. Refusal of exemptions harms patients: advocate John Gilchrist, communications director for TheraPsil, a Canadian non-profit organization that advocates for legal access to psychedelic therapy, was "elated" with this week's decision, which he called a "very long time coming." Gilchrist hopes this leads the current health minister to open up access to therapies by training more professionals who can help treat patients with debilitating migraines or depression. He says Health Canada's refusal to grant the exemptions is "harming health-care professionals and, very importantly, patients who are the most vulnerable in Canada." The Federal Court of Appeal's decision noted that Health Canada changed its position on psilocybin exemptions between 2020 and 2022 with no clear explanation. In 2020, then Health Minister Patty Hajdu granted exemptions to 19 health-care practitioners. This was reversed in 2022 under Carolyn Bennett, the then minister of mental health and addictions and the associate minister of health. "Health Canada is not aware of peer-reviewed clinical evidence to demonstrate that health-care professionals need to take a psychedelic drug in order to appreciate what the patient experiences," the ministry is quoted as saying in the federal court decision this week. But Federal Court of Appeal Justice Douglas Rennie wrote in his decision Wednesday that "nearly identical exemption requests" were granted in one case and denied arbitrarily in the other. "The Minister can't make such a significant and abrupt shift without explanation," he wrote. WATCH | Psychotherapist explains what a medical magic mushroom trip will look like: What a magic mushroom trip will look like for medical participants 1 year ago Duration 1:32 Health Canada has approved a study with 20 Londoners who suffer from PTSD to experience therapy under the influence of psilocybin, the active ingredient in psychedelic mushrooms. Psychotherapist Jared Dalton will oversee the therapy. He explains how it will work. Wins will open access to treatments: lawyer Ottawa lawyer Nicholas Pope says this is the latest in legal wins that will help open up access to psychedelic treatments. Pope, lawyer for the appellants, said the health-care workers were approved in 2020, then denied based on a lack of scientific evidence of efficacy. "Health Canada didn't demand that level of evidence in 2020 and now is demanding it," he said. In May 2024, a Calgary man named Jody Lance who suffers debilitating cluster headaches was the first to win a Federal Court battle forcing Health Canada to reconsider his bid for legal access to psilocybin to treat his extreme pain. His case was withdrawn after he got approval for an exemption this year. Requests to access controlled substances in special medical circumstances are filed through Health Canada's Special Access Program (SAP). Lance's initial application under the SAP to help treat his pain was denied due to lack of research into the efficacy of psilocybin to treat cluster headaches. Canadians have had limited legal access to psilocybin under the SAP since 2022. Health Canada approved 56 SAP requests in 2022, 106 in 2023 and 85 as of October 2024.
CBC
3 hours ago
- CBC
Vancouver Island family heartbroken as B.C. stops funding $1M drug for girl with terminal condition
A Vancouver Island family is in shock after learning the British Columbia government will stop funding an extremely expensive medication their young daughter needs for a rare genetic condition. Nine-year-old Charleigh Pollock is the only person in B.C. with Batten disease, or neuronal ceroid lipofuscinosis type 2 (CLN2). It's a rare and terminal genetic disorder that causes multiple seizures daily, eventually causing brain damage. Pollock's mother, Jori Fales, said the family is still processing the news, announced Wednesday, that the B.C. government will pull funding for Pollock's access to Brineura, a $1-million-per-year medication which is given through an infusion of fluid to the brain to slow the progression of CLN2. "Emotions have gone from sheer heartbreak to anger to sadness; it's just been a roller-coaster the last 24 hours," Fales said. Thursday marked Pollock's last infusion of Brineura. Fales called the government's decision to pull funding with one day's notice before the last infusion "a little heartless." She said her daughter has been let down. "At the end of the day, it should have always been the decision of her medical care team, and her family and Charleigh. And none of that has happened here." On Thursday, B.C. Minister of Health Josie Osborne said it was a tough decision to end the funding. She said the cost of the medication had nothing to do with the reason the funding was pulled, but that it was determined Pollock's condition had deteriorated to the point where she met "discontinuation criteria" for Brineura. "Clinical evidence shows that once a patient has declined in their motor and language functions by a certain amount, Brineura no longer has the benefit of slowing down the progression of the disease, although patients can continue to live on into mid-adolescence," Osborne said. Fales denied that her daughter's condition has worsened. "Charleigh is not in advanced progression of her disease. This is simply not true," she said. Dr. Ineka Whiteman, the head of research and medical affairs for the Batten Disease Support and Research Association U.S. and Australia and head of the Batten Disease Global Research Initiative, called the B.C. government's decision "appalling." She expressed frustration with the provincial government's emphasis on criteria to discontinue the medicine, which she said is based on old clinical trials. She added other families around the world are becoming concerned their access to the medication may also be reconsidered. "This is not just about a single child. This is really setting a very, very dangerous precedent." Fales said she plans to share her daughter's journey and advocate for others dealing with the disease.
CTV News
4 hours ago
- CTV News
Water quality advisory issued for Trestle Creek Golf Resort Beach
Alberta Health Services (AHS) has issued a water quality advisory for Trestle Creek Golf Resort Beach due to high levels of fecal bacteria. At current levels, gastrointestinal illness may result from consuming the water. There is also a possibility of skin, ear and eye infection if exposed to the water. People are advised not to swim or wade at the beach area. The Trestle Creek Golf Resort is approximately 92 kilometres west of Edmonton.
